Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination

被引:0
|
作者
Rapoport, Bernardo [1 ]
Smit, Teresa [1 ]
Heyman, Liezl [1 ]
Moosa, Farhana [1 ]
Benn, Carol Ann [2 ]
机构
[1] Med Oncol Ctr Rosebank, Johannesburg, South Africa
[2] Netcare Breast Care Ctr, Johannesburg, South Africa
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS3-12
引用
收藏
页数:1
相关论文
共 50 条
  • [41] High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alba, Emilio
    Lluch, Ana
    Ribelles, Nuria
    Anton-Torres, Antonio
    Sanchez-Rovira, Pedro
    Albanell, Joan
    Calvo, Lourdes
    Lopez Garcia-Asenjo, Jose Antonio
    Palacios, Jose
    Ignacio Chacon, Jose
    Ruiz, Amparo
    De la Haba-Rodriguez, Juan
    Segui-Palmer, Miguel A.
    Cirauqui, Beatriz
    Margeli, Mireia
    Plazaola, Arrate
    Barnadas, Agusti
    Casas, Maribel
    Caballero, Rosalia
    Carrasco, Eva
    Rojo, Federico
    [J]. ONCOLOGIST, 2016, 21 (02): : 150 - 155
  • [42] Complete pathological response following neoadjuvant chemotherapy in early breast cancer: a retrospective study
    Janjua, Tanzeel
    Ramanujam, Deivasikamani
    Mausam, Iqtedar
    Ali, Waqas
    Butt, Mohammad
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S127 - S127
  • [43] GATA-3 Expression Is Not Associated With Complete Pathological Response in Triple Negative Breast Patients Treated With Neoadjuvant Chemotherapy
    Wasserman, Jason
    Williams, Phillip
    Islam, Shahidul
    Robertson, Susan
    [J]. MODERN PATHOLOGY, 2015, 28 : 73A - 73A
  • [44] GATA-3 Expression Is Not Associated With Complete Pathological Response in Triple Negative Breast Patients Treated With Neoadjuvant Chemotherapy
    Wasserman, Jason
    Williams, Phillip
    Islam, Shahidul
    Robertson, Susan
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 73A - 73A
  • [45] Predictive markers of complete pathological response to neoadjuvant chemoimmunotherapy in triple negative breast cancer.
    Cankar, Kaja
    Auprih, Masa
    Ovcaricek, Tanja
    Kovac, Anja
    Sarvari, Natasa Snoj
    Dobovisek, Luka
    Borstnar, Simona
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
    Francisco Acevedo
    Benjamín Walbaum
    Sabrina Muñiz
    Militza Petric
    Raúl Martínez
    Constanza Guerra
    Marisel Navarro
    Miguel Córdova-Delgado
    Mauricio P. Pinto
    Cesar Sánchez
    [J]. Scientific Reports, 12
  • [47] Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
    Acevedo, Francisco
    Walbaum, Benjamin
    Muniz, Sabrina
    Petric, Militza
    Martinez, Raul
    Guerra, Constanza
    Navarro, Marisel
    Cordova-Delgado, Miguel
    Pinto, Mauricio P.
    Sanchez, Cesar
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [48] Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
    Atkins, Jordan J.
    Appleton, Catherine M.
    Fisher, Carla S.
    Gao, Feng
    Margenthaler, Julie A.
    [J]. JOURNAL OF ONCOLOGY, 2013, 2013
  • [49] Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
    Sakuma, Kaori
    Kurosumi, Masafumi
    Oba, Hanako
    Kobayashi, Yasuhito
    Takei, Hiroyuki
    Inoue, Kenichi
    Tabei, Toshio
    Oyama, Tetsunari
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (02) : 257 - 264
  • [50] Neoadjuvant chemotherapy regimens for triple negative breast cancer patients
    Gigolaeva, L.
    Krivorotko, P.
    Zhiltsova, E.
    Dashyan, G.
    Chadjimatova, S.
    Pesotckiy, R.
    Emelyanov, A.
    Semiglazov, V.
    [J]. BREAST, 2019, 44 : S70 - S70